These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29659748)

  • 1. Burden, Etiology, and Risk Factors of Respiratory Virus Infections Among Symptomatic Preterm Infants in the Tropics: A Retrospective Single-Center Cohort Study.
    Yeo KT; de la Puerta R; Tee NWS; Thoon KC; Rajadurai VS; Yung CF
    Clin Infect Dis; 2018 Oct; 67(10):1603-1609. PubMed ID: 29659748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
    Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
    Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria.
    Resch B; Sommer C; Nuijten MJ; Seidinger S; Walter E; Schoellbauer V; Mueller WD
    Pediatr Infect Dis J; 2012 Jan; 31(1):e1-8. PubMed ID: 21960187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis.
    Stevens TP; Sinkin RA; Hall CB; Maniscalco WM; McConnochie KM
    Arch Pediatr Adolesc Med; 2000 Jan; 154(1):55-61. PubMed ID: 10632251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea.
    Lee JH; Kim CS; Chang YS; Choi JH;
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S104-10. PubMed ID: 26566351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower respiratory tract illness and RSV prophylaxis in very premature infants.
    Lacaze-Masmonteil T; Truffert P; Pinquier D; Daoud P; Goldfarb G; Vicaut E; Fauroux B
    Arch Dis Child; 2004 Jun; 89(6):562-7. PubMed ID: 15155404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.
    Madhi SA; Kuwanda L; Cutland C; Klugman KP
    J Clin Virol; 2006 Jul; 36(3):215-21. PubMed ID: 16678480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus hospitalizations in infants of 28 weeks gestational age and less in the palivizumab era.
    Resch B; Egger B; Kurath-Koller S; Urlesberger B
    Int J Infect Dis; 2017 Apr; 57():50-53. PubMed ID: 28163166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Respiratory morbidity after hospital discharge in premature infants born at < or = 32 weeks gestation with bronchopulmonary dysplasia].
    Pérez Pérez G; Navarro Merino M; Romero Pérez MM; Sáenz Reguera C; Pons Tubío A; Polo Padillo J
    An Pediatr (Barc); 2004 Feb; 60(2):117-24. PubMed ID: 14757014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Have Changing Palivizumab Administration Policies Led to More Respiratory Morbidity in Infants Born at 32-35 Weeks?
    Olicker A; Li H; Tatsuoka C; Ross K; Trembath A; Hibbs AM
    J Pediatr; 2016 Apr; 171():31-7. PubMed ID: 26724119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].
    Resch B; Müller W
    Klin Padiatr; 1999; 211(6):450-5. PubMed ID: 10592925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for acute respiratory syncytial virus infection of lower respiratory tract in hospitalized infants].
    Zhang X; Liu L; Shi P; Jiang G; Jia P; Wang C; Wang L; Qian L
    Zhonghua Er Ke Za Zhi; 2014 May; 52(5):373-7. PubMed ID: 24969937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
    Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
    An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of health care resource utilization among preterm and term infants hospitalized with Human Respiratory Syncytial Virus infections: A systematic review and meta-analysis of retrospective cohort studies.
    Kenmoe S; Kengne-Nde C; Modiyinji AF; La Rosa G; Njouom R
    PLoS One; 2020; 15(2):e0229357. PubMed ID: 32084214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.
    Carbonell-Estrany X; Quero J; Bustos G; Cotero A; Doménech E; Figueras-Aloy J; Fraga JM; García LG; García-Alix A; Del Río MG; Krauel X; Sastre JB; Narbona E; Roqués V; Hernández SS; Zapatero M
    Pediatr Infect Dis J; 2000 Jul; 19(7):592-7. PubMed ID: 10917214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany.
    Liese JG; Grill E; Fischer B; Roeckl-Wiedmann I; Carr D; Belohradsky BH;
    Eur J Pediatr; 2003 Apr; 162(4):230-6. PubMed ID: 12647195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seasonal peaks and risk factors of respiratory syncytial virus infections related hospitalization of preterm infants in Taiwan.
    Chi H; Chung CH; Lin YJ; Lin CH
    PLoS One; 2018; 13(5):e0197410. PubMed ID: 29746578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population based external validation of a European predictive model for respiratory syncytial virus hospitalization of premature infants born 33 to 35 weeks of gestational age.
    Stensballe LG; Fullarton JR; Carbonell-Estrany X; Simões EA
    Pediatr Infect Dis J; 2010 Apr; 29(4):374-6. PubMed ID: 20016397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Medical Resources by Preterm Infants Born at Less than 33 Weeks' Gestation Following Discharge from the Neonatal Intensive Care Unit in Korea.
    Lee JH; Chang YS;
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S95-S103. PubMed ID: 26566364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.